Why the study?
To determine the prevalence of silent brain infarction and cerebral small vessel disease across various heart diseases, compare patients with and without recent stroke, and explore their associations.
Does the presence of heart disease increase the prevalence of silent brain infarction and cerebral small vessel disease in adults?
Meta-Analysis
Does the presence of heart disease increase the prevalence of silent brain infarction and cerebral small vessel disease in adults?
Effect estimate: PR 2.3 (95% CI 1.6-3.1)
p-value: p=<0.05
Adults with various forms of heart disease have a significantly higher prevalence of silent brain infarction and white matter hyperintensities compared to individuals without heart disease.
BACKGROUND AND OBJECTIVES: To determine the prevalence of silent brain infarction (SBI) and cerebral small vessel disease (CSVD) in adults with atrial fibrillation (AF), coronary artery disease, heart failure or cardiomyopathy, heart valve disease, and patent foramen ovale (PFO), with comparisons between those with and without recent stroke and an exploration of associations between heart disease and SBI/CSVD. METHODS: Medline, Embase, and Cochrane Library were systematically searched for hospital-based or community-based studies reporting SBI/CSVD in people with heart disease. Data were extracted from eligible studies. Outcomes were SBI (primary) and individual CSVD subtypes. Summary prevalence (95% confidence intervals [CIs]) were obtained using random-effects meta-analysis. Pooled prevalence ratios (PRs) (95% CI) were calculated to compare those with heart disease with available control participants without heart disease from studies. RESULTS: <0.05). There was no evidence of a difference in the prevalence of microbleed between those with and without heart disease (PR [95% CI] 1.1 [0.7-1.7]), but a difference was seen in the prevalence of SBI and WMH (PR [95% CI] 2.3 [1.6-3.1] and 1.7 [1.1-2.6], respectively). DISCUSSION: People with heart disease have a high prevalence of SBI (and CSVD), which is similar in those with vs without recent stroke. More research is required to assess causal links and implications for management. TRIAL REGISTRATION INFORMATION: PROSPERO CRD42022378272 (crd.york.ac.uk/PROSPERO/).
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2024) conducted a meta-analysis in Heart disease. Heart disease vs. Participants without heart disease was evaluated on Silent brain infarction (SBI) (PR 2.3, 95% CI 1.6-3.1, p=<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: